nodes	percent_of_prediction	percent_of_DWPC	metapath
Nabumetone—osteoarthritis—Methylprednisolone—ankylosing spondylitis	0.304	0.5	CpDpCtD
Nabumetone—osteoarthritis—Prednisone—ankylosing spondylitis	0.304	0.5	CpDpCtD
Nabumetone—PTGS2—Sulfasalazine—ankylosing spondylitis	0.0784	0.238	CbGbCtD
Nabumetone—PTGS2—Triamcinolone—ankylosing spondylitis	0.0784	0.238	CbGbCtD
Nabumetone—PTGS2—Betamethasone—ankylosing spondylitis	0.0672	0.204	CbGbCtD
Nabumetone—PTGS1—Sulfasalazine—ankylosing spondylitis	0.0662	0.201	CbGbCtD
Nabumetone—PTGS2—Dexamethasone—ankylosing spondylitis	0.0391	0.119	CbGbCtD
Nabumetone—PTGS2—Fluocinonide—Methylprednisolone—ankylosing spondylitis	0.000512	0.159	CbGdCrCtD
Nabumetone—PTGS2—Fluocinonide—Dexamethasone—ankylosing spondylitis	0.000504	0.156	CbGdCrCtD
Nabumetone—PTGS2—Fluocinonide—Betamethasone—ankylosing spondylitis	0.000504	0.156	CbGdCrCtD
Nabumetone—PTGS2—Fluocinonide—Triamcinolone—ankylosing spondylitis	0.000492	0.153	CbGdCrCtD
Nabumetone—PTGS2—Fluticasone Propionate—Methylprednisolone—ankylosing spondylitis	0.000309	0.0958	CbGdCrCtD
Nabumetone—PTGS2—Fluticasone Propionate—Dexamethasone—ankylosing spondylitis	0.000304	0.0943	CbGdCrCtD
Nabumetone—PTGS2—Fluticasone Propionate—Betamethasone—ankylosing spondylitis	0.000304	0.0943	CbGdCrCtD
Nabumetone—PTGS2—Fluticasone Propionate—Triamcinolone—ankylosing spondylitis	0.000297	0.0921	CbGdCrCtD
Nabumetone—Myocardial infarction—Prednisone—ankylosing spondylitis	0.000164	0.00279	CcSEcCtD
Nabumetone—Toxic epidermal necrolysis—Methotrexate—ankylosing spondylitis	0.000163	0.00278	CcSEcCtD
Nabumetone—Malaise—Prednisolone—ankylosing spondylitis	0.000162	0.00276	CcSEcCtD
Nabumetone—Vertigo—Prednisolone—ankylosing spondylitis	0.000162	0.00275	CcSEcCtD
Nabumetone—Syncope—Prednisolone—ankylosing spondylitis	0.000161	0.00275	CcSEcCtD
Nabumetone—Loss of consciousness—Prednisolone—ankylosing spondylitis	0.000158	0.00269	CcSEcCtD
Nabumetone—Asthma—Methotrexate—ankylosing spondylitis	0.000157	0.00267	CcSEcCtD
Nabumetone—Hypertension—Prednisolone—ankylosing spondylitis	0.000155	0.00264	CcSEcCtD
Nabumetone—Arrhythmia—Betamethasone—ankylosing spondylitis	0.000154	0.00262	CcSEcCtD
Nabumetone—Arrhythmia—Dexamethasone—ankylosing spondylitis	0.000154	0.00262	CcSEcCtD
Nabumetone—Pancreatitis—Methotrexate—ankylosing spondylitis	0.000154	0.00262	CcSEcCtD
Nabumetone—Ill-defined disorder—Triamcinolone—ankylosing spondylitis	0.000153	0.00261	CcSEcCtD
Nabumetone—Ill-defined disorder—Methylprednisolone—ankylosing spondylitis	0.000153	0.00261	CcSEcCtD
Nabumetone—Alopecia—Betamethasone—ankylosing spondylitis	0.000152	0.00259	CcSEcCtD
Nabumetone—Alopecia—Dexamethasone—ankylosing spondylitis	0.000152	0.00259	CcSEcCtD
Nabumetone—Discomfort—Prednisolone—ankylosing spondylitis	0.000151	0.00257	CcSEcCtD
Nabumetone—Angioedema—Triamcinolone—ankylosing spondylitis	0.000151	0.00257	CcSEcCtD
Nabumetone—Haemoglobin—Prednisone—ankylosing spondylitis	0.000151	0.00257	CcSEcCtD
Nabumetone—Angioedema—Methylprednisolone—ankylosing spondylitis	0.000151	0.00257	CcSEcCtD
Nabumetone—Haemorrhage—Prednisone—ankylosing spondylitis	0.00015	0.00256	CcSEcCtD
Nabumetone—Malaise—Triamcinolone—ankylosing spondylitis	0.000149	0.00254	CcSEcCtD
Nabumetone—Malaise—Methylprednisolone—ankylosing spondylitis	0.000149	0.00253	CcSEcCtD
Nabumetone—Vertigo—Triamcinolone—ankylosing spondylitis	0.000149	0.00253	CcSEcCtD
Nabumetone—Syncope—Triamcinolone—ankylosing spondylitis	0.000148	0.00252	CcSEcCtD
Nabumetone—Vertigo—Methylprednisolone—ankylosing spondylitis	0.000148	0.00252	CcSEcCtD
Nabumetone—Syncope—Methylprednisolone—ankylosing spondylitis	0.000148	0.00252	CcSEcCtD
Nabumetone—Oedema—Prednisolone—ankylosing spondylitis	0.000147	0.0025	CcSEcCtD
Nabumetone—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.000147	0.0025	CcSEcCtD
Nabumetone—Dysuria—Methotrexate—ankylosing spondylitis	0.000147	0.00249	CcSEcCtD
Nabumetone—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.000145	0.00247	CcSEcCtD
Nabumetone—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.000145	0.00247	CcSEcCtD
Nabumetone—Shock—Prednisolone—ankylosing spondylitis	0.000144	0.00246	CcSEcCtD
Nabumetone—Erectile dysfunction—Methotrexate—ankylosing spondylitis	0.000144	0.00246	CcSEcCtD
Nabumetone—Cough—Triamcinolone—ankylosing spondylitis	0.000144	0.00246	CcSEcCtD
Nabumetone—Photosensitivity reaction—Methotrexate—ankylosing spondylitis	0.000143	0.00244	CcSEcCtD
Nabumetone—Hypertension—Triamcinolone—ankylosing spondylitis	0.000143	0.00243	CcSEcCtD
Nabumetone—Hypertension—Methylprednisolone—ankylosing spondylitis	0.000142	0.00243	CcSEcCtD
Nabumetone—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.000142	0.00242	CcSEcCtD
Nabumetone—Pneumonia—Methotrexate—ankylosing spondylitis	0.000141	0.00239	CcSEcCtD
Nabumetone—Anxiety—Methylprednisolone—ankylosing spondylitis	0.00014	0.00238	CcSEcCtD
Nabumetone—Depression—Methotrexate—ankylosing spondylitis	0.000139	0.00237	CcSEcCtD
Nabumetone—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.000139	0.00237	CcSEcCtD
Nabumetone—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.000139	0.00237	CcSEcCtD
Nabumetone—Discomfort—Triamcinolone—ankylosing spondylitis	0.000139	0.00237	CcSEcCtD
Nabumetone—Discomfort—Methylprednisolone—ankylosing spondylitis	0.000139	0.00236	CcSEcCtD
Nabumetone—Stevens-Johnson syndrome—Methotrexate—ankylosing spondylitis	0.000139	0.00236	CcSEcCtD
Nabumetone—Dry mouth—Triamcinolone—ankylosing spondylitis	0.000138	0.00234	CcSEcCtD
Nabumetone—Renal failure—Methotrexate—ankylosing spondylitis	0.000137	0.00234	CcSEcCtD
Nabumetone—Angioedema—Betamethasone—ankylosing spondylitis	0.000137	0.00233	CcSEcCtD
Nabumetone—Angioedema—Dexamethasone—ankylosing spondylitis	0.000137	0.00233	CcSEcCtD
Nabumetone—Stomatitis—Methotrexate—ankylosing spondylitis	0.000136	0.00232	CcSEcCtD
Nabumetone—Confusional state—Methylprednisolone—ankylosing spondylitis	0.000136	0.00231	CcSEcCtD
Nabumetone—Malaise—Dexamethasone—ankylosing spondylitis	0.000135	0.0023	CcSEcCtD
Nabumetone—Malaise—Betamethasone—ankylosing spondylitis	0.000135	0.0023	CcSEcCtD
Nabumetone—Oedema—Triamcinolone—ankylosing spondylitis	0.000135	0.0023	CcSEcCtD
Nabumetone—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.000135	0.0023	CcSEcCtD
Nabumetone—Vertigo—Betamethasone—ankylosing spondylitis	0.000135	0.00229	CcSEcCtD
Nabumetone—Vertigo—Dexamethasone—ankylosing spondylitis	0.000135	0.00229	CcSEcCtD
Nabumetone—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.000135	0.00229	CcSEcCtD
Nabumetone—Syncope—Betamethasone—ankylosing spondylitis	0.000135	0.00229	CcSEcCtD
Nabumetone—Syncope—Dexamethasone—ankylosing spondylitis	0.000135	0.00229	CcSEcCtD
Nabumetone—Arrhythmia—Prednisone—ankylosing spondylitis	0.000134	0.00228	CcSEcCtD
Nabumetone—Haematuria—Methotrexate—ankylosing spondylitis	0.000133	0.00227	CcSEcCtD
Nabumetone—Shock—Triamcinolone—ankylosing spondylitis	0.000133	0.00226	CcSEcCtD
Nabumetone—Insomnia—Prednisolone—ankylosing spondylitis	0.000133	0.00226	CcSEcCtD
Nabumetone—Alopecia—Prednisone—ankylosing spondylitis	0.000133	0.00226	CcSEcCtD
Nabumetone—Shock—Methylprednisolone—ankylosing spondylitis	0.000133	0.00226	CcSEcCtD
Nabumetone—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000132	0.00225	CcSEcCtD
Nabumetone—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000132	0.00225	CcSEcCtD
Nabumetone—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000132	0.00224	CcSEcCtD
Nabumetone—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.00013	0.00222	CcSEcCtD
Nabumetone—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.00013	0.00222	CcSEcCtD
Nabumetone—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.00013	0.00222	CcSEcCtD
Nabumetone—Hypertension—Betamethasone—ankylosing spondylitis	0.00013	0.00221	CcSEcCtD
Nabumetone—Hypertension—Dexamethasone—ankylosing spondylitis	0.00013	0.00221	CcSEcCtD
Nabumetone—Anxiety—Dexamethasone—ankylosing spondylitis	0.000127	0.00217	CcSEcCtD
Nabumetone—Anxiety—Betamethasone—ankylosing spondylitis	0.000127	0.00217	CcSEcCtD
Nabumetone—Discomfort—Dexamethasone—ankylosing spondylitis	0.000126	0.00215	CcSEcCtD
Nabumetone—Discomfort—Betamethasone—ankylosing spondylitis	0.000126	0.00215	CcSEcCtD
Nabumetone—Haemoglobin—Methotrexate—ankylosing spondylitis	0.000126	0.00215	CcSEcCtD
Nabumetone—Haemorrhage—Methotrexate—ankylosing spondylitis	0.000125	0.00214	CcSEcCtD
Nabumetone—Oedema—Dexamethasone—ankylosing spondylitis	0.000122	0.00208	CcSEcCtD
Nabumetone—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000122	0.00208	CcSEcCtD
Nabumetone—Oedema—Betamethasone—ankylosing spondylitis	0.000122	0.00208	CcSEcCtD
Nabumetone—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000122	0.00208	CcSEcCtD
Nabumetone—Insomnia—Triamcinolone—ankylosing spondylitis	0.000122	0.00208	CcSEcCtD
Nabumetone—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000122	0.00207	CcSEcCtD
Nabumetone—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000121	0.00206	CcSEcCtD
Nabumetone—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000121	0.00206	CcSEcCtD
Nabumetone—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000121	0.00206	CcSEcCtD
Nabumetone—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000121	0.00206	CcSEcCtD
Nabumetone—Visual impairment—Methotrexate—ankylosing spondylitis	0.000121	0.00206	CcSEcCtD
Nabumetone—Anaemia—Prednisone—ankylosing spondylitis	0.000121	0.00206	CcSEcCtD
Nabumetone—Shock—Betamethasone—ankylosing spondylitis	0.00012	0.00205	CcSEcCtD
Nabumetone—Shock—Dexamethasone—ankylosing spondylitis	0.00012	0.00205	CcSEcCtD
Nabumetone—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.00012	0.00205	CcSEcCtD
Nabumetone—Agitation—Prednisone—ankylosing spondylitis	0.00012	0.00204	CcSEcCtD
Nabumetone—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.00012	0.00204	CcSEcCtD
Nabumetone—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.00012	0.00204	CcSEcCtD
Nabumetone—Angioedema—Prednisone—ankylosing spondylitis	0.000119	0.00203	CcSEcCtD
Nabumetone—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000119	0.00202	CcSEcCtD
Nabumetone—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.000119	0.00202	CcSEcCtD
Nabumetone—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000119	0.00202	CcSEcCtD
Nabumetone—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000118	0.00202	CcSEcCtD
Nabumetone—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000118	0.00202	CcSEcCtD
Nabumetone—Malaise—Prednisone—ankylosing spondylitis	0.000118	0.00201	CcSEcCtD
Nabumetone—Vertigo—Prednisone—ankylosing spondylitis	0.000117	0.002	CcSEcCtD
Nabumetone—Syncope—Prednisone—ankylosing spondylitis	0.000117	0.00199	CcSEcCtD
Nabumetone—Tinnitus—Methotrexate—ankylosing spondylitis	0.000117	0.00199	CcSEcCtD
Nabumetone—Anorexia—Dexamethasone—ankylosing spondylitis	0.000117	0.00199	CcSEcCtD
Nabumetone—Anorexia—Betamethasone—ankylosing spondylitis	0.000117	0.00199	CcSEcCtD
Nabumetone—Urticaria—Prednisolone—ankylosing spondylitis	0.000117	0.00198	CcSEcCtD
Nabumetone—Fatigue—Triamcinolone—ankylosing spondylitis	0.000116	0.00198	CcSEcCtD
Nabumetone—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000116	0.00198	CcSEcCtD
Nabumetone—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000115	0.00196	CcSEcCtD
Nabumetone—Hypertension—Prednisone—ankylosing spondylitis	0.000113	0.00192	CcSEcCtD
Nabumetone—Chills—Methotrexate—ankylosing spondylitis	0.000113	0.00192	CcSEcCtD
Nabumetone—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000111	0.00189	CcSEcCtD
Nabumetone—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000111	0.00189	CcSEcCtD
Nabumetone—Anxiety—Prednisone—ankylosing spondylitis	0.000111	0.00189	CcSEcCtD
Nabumetone—Alopecia—Methotrexate—ankylosing spondylitis	0.000111	0.00189	CcSEcCtD
Nabumetone—Insomnia—Betamethasone—ankylosing spondylitis	0.000111	0.00189	CcSEcCtD
Nabumetone—Insomnia—Dexamethasone—ankylosing spondylitis	0.000111	0.00189	CcSEcCtD
Nabumetone—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.00011	0.00187	CcSEcCtD
Nabumetone—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.00011	0.00187	CcSEcCtD
Nabumetone—Paraesthesia—Betamethasone—ankylosing spondylitis	0.00011	0.00187	CcSEcCtD
Nabumetone—Discomfort—Prednisone—ankylosing spondylitis	0.00011	0.00187	CcSEcCtD
Nabumetone—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000108	0.00184	CcSEcCtD
Nabumetone—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000108	0.00184	CcSEcCtD
Nabumetone—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000108	0.00184	CcSEcCtD
Nabumetone—Urticaria—Triamcinolone—ankylosing spondylitis	0.000107	0.00183	CcSEcCtD
Nabumetone—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000107	0.00182	CcSEcCtD
Nabumetone—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000107	0.00182	CcSEcCtD
Nabumetone—Oedema—Prednisone—ankylosing spondylitis	0.000107	0.00182	CcSEcCtD
Nabumetone—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000107	0.00182	CcSEcCtD
Nabumetone—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000106	0.00181	CcSEcCtD
Nabumetone—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000106	0.00181	CcSEcCtD
Nabumetone—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000106	0.00181	CcSEcCtD
Nabumetone—Fatigue—Betamethasone—ankylosing spondylitis	0.000106	0.0018	CcSEcCtD
Nabumetone—Fatigue—Dexamethasone—ankylosing spondylitis	0.000106	0.0018	CcSEcCtD
Nabumetone—Shock—Prednisone—ankylosing spondylitis	0.000105	0.00179	CcSEcCtD
Nabumetone—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000103	0.00176	CcSEcCtD
Nabumetone—Anorexia—Prednisone—ankylosing spondylitis	0.000102	0.00173	CcSEcCtD
Nabumetone—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000101	0.00172	CcSEcCtD
Nabumetone—Anaemia—Methotrexate—ankylosing spondylitis	0.000101	0.00172	CcSEcCtD
Nabumetone—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000101	0.00172	CcSEcCtD
Nabumetone—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000101	0.00172	CcSEcCtD
Nabumetone—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.0001	0.0017	CcSEcCtD
Nabumetone—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.0001	0.0017	CcSEcCtD
Nabumetone—Hypersensitivity—Triamcinolone—ankylosing spondylitis	9.94e-05	0.00169	CcSEcCtD
Nabumetone—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	9.92e-05	0.00169	CcSEcCtD
Nabumetone—Malaise—Methotrexate—ankylosing spondylitis	9.85e-05	0.00168	CcSEcCtD
Nabumetone—Vertigo—Methotrexate—ankylosing spondylitis	9.81e-05	0.00167	CcSEcCtD
Nabumetone—Leukopenia—Methotrexate—ankylosing spondylitis	9.78e-05	0.00166	CcSEcCtD
Nabumetone—Urticaria—Dexamethasone—ankylosing spondylitis	9.73e-05	0.00166	CcSEcCtD
Nabumetone—Urticaria—Betamethasone—ankylosing spondylitis	9.73e-05	0.00166	CcSEcCtD
Nabumetone—Dizziness—Prednisolone—ankylosing spondylitis	9.71e-05	0.00165	CcSEcCtD
Nabumetone—Asthenia—Triamcinolone—ankylosing spondylitis	9.68e-05	0.00165	CcSEcCtD
Nabumetone—Body temperature increased—Dexamethasone—ankylosing spondylitis	9.68e-05	0.00165	CcSEcCtD
Nabumetone—Abdominal pain—Betamethasone—ankylosing spondylitis	9.68e-05	0.00165	CcSEcCtD
Nabumetone—Body temperature increased—Betamethasone—ankylosing spondylitis	9.68e-05	0.00165	CcSEcCtD
Nabumetone—Abdominal pain—Dexamethasone—ankylosing spondylitis	9.68e-05	0.00165	CcSEcCtD
Nabumetone—Asthenia—Methylprednisolone—ankylosing spondylitis	9.66e-05	0.00164	CcSEcCtD
Nabumetone—Insomnia—Prednisone—ankylosing spondylitis	9.65e-05	0.00164	CcSEcCtD
Nabumetone—Paraesthesia—Prednisone—ankylosing spondylitis	9.58e-05	0.00163	CcSEcCtD
Nabumetone—Pruritus—Triamcinolone—ankylosing spondylitis	9.55e-05	0.00163	CcSEcCtD
Nabumetone—Cough—Methotrexate—ankylosing spondylitis	9.53e-05	0.00162	CcSEcCtD
Nabumetone—Pruritus—Methylprednisolone—ankylosing spondylitis	9.53e-05	0.00162	CcSEcCtD
Nabumetone—Dyspepsia—Prednisone—ankylosing spondylitis	9.39e-05	0.0016	CcSEcCtD
Nabumetone—Decreased appetite—Prednisone—ankylosing spondylitis	9.27e-05	0.00158	CcSEcCtD
Nabumetone—Rash—Prednisolone—ankylosing spondylitis	9.25e-05	0.00158	CcSEcCtD
Nabumetone—Dermatitis—Prednisolone—ankylosing spondylitis	9.25e-05	0.00157	CcSEcCtD
Nabumetone—Diarrhoea—Methylprednisolone—ankylosing spondylitis	9.21e-05	0.00157	CcSEcCtD
Nabumetone—Fatigue—Prednisone—ankylosing spondylitis	9.2e-05	0.00157	CcSEcCtD
Nabumetone—Headache—Prednisolone—ankylosing spondylitis	9.2e-05	0.00157	CcSEcCtD
Nabumetone—Discomfort—Methotrexate—ankylosing spondylitis	9.19e-05	0.00156	CcSEcCtD
Nabumetone—Constipation—Prednisone—ankylosing spondylitis	9.12e-05	0.00155	CcSEcCtD
Nabumetone—Confusional state—Methotrexate—ankylosing spondylitis	8.99e-05	0.00153	CcSEcCtD
Nabumetone—Dizziness—Triamcinolone—ankylosing spondylitis	8.93e-05	0.00152	CcSEcCtD
Nabumetone—Anaphylactic shock—Methotrexate—ankylosing spondylitis	8.91e-05	0.00152	CcSEcCtD
Nabumetone—Dizziness—Methylprednisolone—ankylosing spondylitis	8.91e-05	0.00152	CcSEcCtD
Nabumetone—Feeling abnormal—Prednisone—ankylosing spondylitis	8.79e-05	0.0015	CcSEcCtD
Nabumetone—Asthenia—Dexamethasone—ankylosing spondylitis	8.79e-05	0.0015	CcSEcCtD
Nabumetone—Asthenia—Betamethasone—ankylosing spondylitis	8.79e-05	0.0015	CcSEcCtD
Nabumetone—Thrombocytopenia—Methotrexate—ankylosing spondylitis	8.73e-05	0.00149	CcSEcCtD
Nabumetone—Gastrointestinal pain—Prednisone—ankylosing spondylitis	8.72e-05	0.00148	CcSEcCtD
Nabumetone—Nausea—Prednisolone—ankylosing spondylitis	8.72e-05	0.00148	CcSEcCtD
Nabumetone—Pruritus—Betamethasone—ankylosing spondylitis	8.67e-05	0.00147	CcSEcCtD
Nabumetone—Pruritus—Dexamethasone—ankylosing spondylitis	8.67e-05	0.00147	CcSEcCtD
Nabumetone—Hyperhidrosis—Methotrexate—ankylosing spondylitis	8.62e-05	0.00147	CcSEcCtD
Nabumetone—Vomiting—Triamcinolone—ankylosing spondylitis	8.58e-05	0.00146	CcSEcCtD
Nabumetone—Vomiting—Methylprednisolone—ankylosing spondylitis	8.56e-05	0.00146	CcSEcCtD
Nabumetone—Rash—Triamcinolone—ankylosing spondylitis	8.51e-05	0.00145	CcSEcCtD
Nabumetone—Dermatitis—Triamcinolone—ankylosing spondylitis	8.5e-05	0.00145	CcSEcCtD
Nabumetone—Anorexia—Methotrexate—ankylosing spondylitis	8.5e-05	0.00145	CcSEcCtD
Nabumetone—Rash—Methylprednisolone—ankylosing spondylitis	8.49e-05	0.00145	CcSEcCtD
Nabumetone—Dermatitis—Methylprednisolone—ankylosing spondylitis	8.48e-05	0.00144	CcSEcCtD
Nabumetone—Urticaria—Prednisone—ankylosing spondylitis	8.47e-05	0.00144	CcSEcCtD
Nabumetone—Headache—Triamcinolone—ankylosing spondylitis	8.46e-05	0.00144	CcSEcCtD
Nabumetone—Headache—Methylprednisolone—ankylosing spondylitis	8.44e-05	0.00144	CcSEcCtD
Nabumetone—Body temperature increased—Prednisone—ankylosing spondylitis	8.43e-05	0.00144	CcSEcCtD
Nabumetone—Abdominal pain—Prednisone—ankylosing spondylitis	8.43e-05	0.00144	CcSEcCtD
Nabumetone—Diarrhoea—Dexamethasone—ankylosing spondylitis	8.38e-05	0.00143	CcSEcCtD
Nabumetone—Diarrhoea—Betamethasone—ankylosing spondylitis	8.38e-05	0.00143	CcSEcCtD
Nabumetone—Dizziness—Dexamethasone—ankylosing spondylitis	8.1e-05	0.00138	CcSEcCtD
Nabumetone—Dizziness—Betamethasone—ankylosing spondylitis	8.1e-05	0.00138	CcSEcCtD
Nabumetone—Insomnia—Methotrexate—ankylosing spondylitis	8.06e-05	0.00137	CcSEcCtD
Nabumetone—Nausea—Triamcinolone—ankylosing spondylitis	8.02e-05	0.00136	CcSEcCtD
Nabumetone—Paraesthesia—Methotrexate—ankylosing spondylitis	8e-05	0.00136	CcSEcCtD
Nabumetone—Nausea—Methylprednisolone—ankylosing spondylitis	8e-05	0.00136	CcSEcCtD
Nabumetone—Dyspnoea—Methotrexate—ankylosing spondylitis	7.95e-05	0.00135	CcSEcCtD
Nabumetone—Somnolence—Methotrexate—ankylosing spondylitis	7.92e-05	0.00135	CcSEcCtD
Nabumetone—Hypersensitivity—Prednisone—ankylosing spondylitis	7.86e-05	0.00134	CcSEcCtD
Nabumetone—Dyspepsia—Methotrexate—ankylosing spondylitis	7.85e-05	0.00134	CcSEcCtD
Nabumetone—Vomiting—Dexamethasone—ankylosing spondylitis	7.79e-05	0.00133	CcSEcCtD
Nabumetone—Vomiting—Betamethasone—ankylosing spondylitis	7.79e-05	0.00133	CcSEcCtD
Nabumetone—Decreased appetite—Methotrexate—ankylosing spondylitis	7.75e-05	0.00132	CcSEcCtD
Nabumetone—Rash—Betamethasone—ankylosing spondylitis	7.72e-05	0.00131	CcSEcCtD
Nabumetone—Rash—Dexamethasone—ankylosing spondylitis	7.72e-05	0.00131	CcSEcCtD
Nabumetone—Dermatitis—Betamethasone—ankylosing spondylitis	7.72e-05	0.00131	CcSEcCtD
Nabumetone—Dermatitis—Dexamethasone—ankylosing spondylitis	7.72e-05	0.00131	CcSEcCtD
Nabumetone—Fatigue—Methotrexate—ankylosing spondylitis	7.69e-05	0.00131	CcSEcCtD
Nabumetone—Headache—Dexamethasone—ankylosing spondylitis	7.67e-05	0.00131	CcSEcCtD
Nabumetone—Headache—Betamethasone—ankylosing spondylitis	7.67e-05	0.00131	CcSEcCtD
Nabumetone—Asthenia—Prednisone—ankylosing spondylitis	7.65e-05	0.0013	CcSEcCtD
Nabumetone—Pruritus—Prednisone—ankylosing spondylitis	7.55e-05	0.00128	CcSEcCtD
Nabumetone—Feeling abnormal—Methotrexate—ankylosing spondylitis	7.35e-05	0.00125	CcSEcCtD
Nabumetone—Diarrhoea—Prednisone—ankylosing spondylitis	7.3e-05	0.00124	CcSEcCtD
Nabumetone—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	7.29e-05	0.00124	CcSEcCtD
Nabumetone—Nausea—Betamethasone—ankylosing spondylitis	7.27e-05	0.00124	CcSEcCtD
Nabumetone—Nausea—Dexamethasone—ankylosing spondylitis	7.27e-05	0.00124	CcSEcCtD
Nabumetone—Urticaria—Methotrexate—ankylosing spondylitis	7.08e-05	0.00121	CcSEcCtD
Nabumetone—Dizziness—Prednisone—ankylosing spondylitis	7.05e-05	0.0012	CcSEcCtD
Nabumetone—Abdominal pain—Methotrexate—ankylosing spondylitis	7.05e-05	0.0012	CcSEcCtD
Nabumetone—Body temperature increased—Methotrexate—ankylosing spondylitis	7.05e-05	0.0012	CcSEcCtD
Nabumetone—Vomiting—Prednisone—ankylosing spondylitis	6.78e-05	0.00115	CcSEcCtD
Nabumetone—Rash—Prednisone—ankylosing spondylitis	6.73e-05	0.00114	CcSEcCtD
Nabumetone—Dermatitis—Prednisone—ankylosing spondylitis	6.72e-05	0.00114	CcSEcCtD
Nabumetone—Headache—Prednisone—ankylosing spondylitis	6.68e-05	0.00114	CcSEcCtD
Nabumetone—Hypersensitivity—Methotrexate—ankylosing spondylitis	6.57e-05	0.00112	CcSEcCtD
Nabumetone—Asthenia—Methotrexate—ankylosing spondylitis	6.4e-05	0.00109	CcSEcCtD
Nabumetone—Nausea—Prednisone—ankylosing spondylitis	6.34e-05	0.00108	CcSEcCtD
Nabumetone—Pruritus—Methotrexate—ankylosing spondylitis	6.31e-05	0.00107	CcSEcCtD
Nabumetone—Diarrhoea—Methotrexate—ankylosing spondylitis	6.1e-05	0.00104	CcSEcCtD
Nabumetone—Dizziness—Methotrexate—ankylosing spondylitis	5.89e-05	0.001	CcSEcCtD
Nabumetone—Vomiting—Methotrexate—ankylosing spondylitis	5.67e-05	0.000965	CcSEcCtD
Nabumetone—Rash—Methotrexate—ankylosing spondylitis	5.62e-05	0.000957	CcSEcCtD
Nabumetone—Dermatitis—Methotrexate—ankylosing spondylitis	5.62e-05	0.000956	CcSEcCtD
Nabumetone—Headache—Methotrexate—ankylosing spondylitis	5.58e-05	0.000951	CcSEcCtD
Nabumetone—Nausea—Methotrexate—ankylosing spondylitis	5.29e-05	0.000901	CcSEcCtD
